. Author manuscript; available in PMC: 2021 Dec 1.

Published in final edited form as: Eur Urol Oncol. 2019 Oct 23;3(6):748–755. doi: 10.1016/j.euo.2019.09.006

Table 5 –

Univariable associations between baseline factors and post-RT biopsy outcome (N = 119)^a,b

		N (#O)	OR	95% CI		p value
Prostate volmne		117 (14)	1.00	0.98–	1.03	0.82
Hormone therapy	Yes	18 (1)	0.40	0.05–	3.25	0.39
Hormone therapy	No	101 (13)	REF
MSK risk	Unfavorable-intermediate	57 (9)	3.19	0.38–	27.05	0.29
	Favorable-intermediate	44 (4)	1.70	0.18–	16.34	0.65
	Low	18 (1)	REF

CI = confidence interval; MSK = Memorial Sloan Kettering Cancer Center; N = total number for level; #O = number of positive biopsies for level; OR = odds ratio; REF= reference; RT = radiotherapy.

Models assess probability of experiencing toxicity: OR >1 indicates higher odds of toxicity; OR <1 indicates lower odds of toxicity.

For continuous factors, odds ratio corresponds to a one-unit increase.